FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 南華期貨股份有限公司 呈交日期: 2026年1月7日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02691 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 107,659,000 | RMB | | 1 | RMB | | 107,659,000 | | 增加 / 減少 (-) | | | 0 | | | | RMB | | 0 | | 本月底結存 | | | 107,659,000 | RMB | | 1 | RMB | | 107,659,000 | | 2. 股份分類 ...

Core Viewpoint - Nanhua Futures Co., Ltd. (02691) saw its stock price rise over 5%, reaching a new high of HKD 11.6, with a trading volume of HKD 22.89 million [1] Group 1: Stock Performance - Nanhua Futures shares increased by 5.07%, trading at HKD 11.6 at the time of reporting [1] - The stock's performance marks a new high since its listing [1] Group 2: Inclusion in Stock Connect - According to Huatai Securities, Nanhua Futures will be included in the Hong Kong Stock Connect on January 19, following the end of the price stabilization period [1] - The price stabilization period for Hong Kong IPOs typically lasts 30 days, starting from the day after the public offering application deadline [1] Group 3: Business Performance and Competitiveness - Huaxi Securities highlighted that Nanhua Futures' overseas business is a core competitive advantage, projecting a revenue of CNY 654 million from overseas financial operations in 2024, representing a year-on-year growth of 15.3% [1] - This overseas revenue is expected to account for 48.3% of total revenue, significantly higher than peers [1] - The company, along with its subsidiaries, holds derivative trading and clearing licenses in major markets such as Hong Kong, the US, the UK, and Singapore, ensuring coverage of all major global futures trading hours [1] - The firm is anticipated to benefit from increased trading activity in dollar-denominated commodities amid heightened foreign exchange volatility [1]

Core Viewpoint - Nanhua Futures Co., Ltd. (02691) has seen a significant increase of over 4% in its stock price, attributed to its competitive advantage in overseas business licenses and its upcoming inclusion in the Hong Kong Stock Connect this month [1] Group 1: Stock Performance - Nanhua Futures shares rose by 4.13%, reaching HKD 10.58, with a trading volume of HKD 26.6181 million [1] Group 2: Business Development - According to Huatai Securities, A+H listed stocks can be included in the Hong Kong Stock Connect without waiting for regular adjustments, allowing Nanhua Futures to be added on January 19 [1] - Huaxi Securities highlighted that Nanhua Futures' overseas business is a core competitive advantage, projecting overseas financial business revenue to reach RMB 654 million in 2024, a year-on-year increase of 15.3%, accounting for 48.3% of total revenue, significantly higher than peers [1] - Nanhua Futures and its subsidiaries hold derivative trading and clearing licenses in major markets such as Hong Kong, the United States, the United Kingdom, and Singapore, achieving full coverage of major global futures trading hours [1]

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示不會就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、美國任何州以及哥倫比亞特區或 任何其他法律禁止此類發佈的司法管轄區內）發佈、刊發或派發。本公告並不構成亦不屬於在 美國境內或於任何其他司法管轄區購買或認購證券的任何要約或招攬的一部分。本公告所述證 券並無亦不會根據《1933年美國證券法》（經不時修訂）（「美國證券法」）或美國任何州或其他司 法管轄區的證券法登記。證券不得在美國境內提呈發售、出售、質押或以其他方式轉讓，惟根 據美國證券法的登記規定及任何適用州證券法獲豁免者除外，或除非符合美國證券法項下的S 規例，否則不得於美國境外提呈發售、出售、質押或以其他方式轉讓。證券不會在美國公開發 售。 本公告僅作說明用途，並不構成收購、購買或認購任何證券的邀請或要約。本公告並非招股章 程。有意投資者於決定是否投資於發售股份前應閱覽招股章程，以獲得有關下文所述 ...

Core Viewpoint - The report highlights the premium rates of AH shares, with Northeast Electric, Zhejiang Shibao, and Hongye Futures leading in premium rates, while CATL, China Merchants Bank, and Heng Rui Medicine are at the bottom of the list [1][2]. Premium Rate Summary - Northeast Electric (00042) has a premium rate of 847.37%, followed by Zhejiang Shibao (01057) at 428.73% and Hongye Futures (03678) at 283.73% [1]. - The lowest premium rates are observed in CATL (03750) at -11.13%, China Merchants Bank (03968) at -3.84%, and Heng Rui Medicine (01276) at 3.17% [1]. Deviation Value Summary - The highest deviation values are recorded for Zhejiang Shibao (01057) at 136.00%, Junda Co. (02865) at 40.42%, and Nanjing Panda Electronics (00553) at 24.71% [1][2]. - The lowest deviation values are seen in Northeast Electric (00042) at -35.46%, GAC Group (02238) at -26.23%, and Nanhua Futures (02691) at -17.44% [1][3]. Top and Bottom AH Shares - The top ten AH shares by premium rate include companies like Sinopec Oilfield Service (01033) with a premium rate of 271.43% and Fudan Zhangjiang (01349) at 250.53% [1]. - The bottom ten AH shares by premium rate include Weichai Power (02338) at 9.88% and WuXi AppTec (02359) at 10.47% [1].

Group 1 - Nanhua Futures Co., Ltd. (02691.HK) experienced a significant increase in stock price, rising over 10% in the afternoon session [1] - As of the report, the stock price is up 7.85%, trading at HKD 10.17 [1] - The trading volume reached HKD 17.3672 million [1]

Core Viewpoint - Nanhua Futures Co., Ltd. has successfully listed on the Hong Kong Stock Exchange, establishing an "A+H" dual capital platform to enhance its global development strategy [1] Group 1: Company Overview - Nanhua Futures shares rose over 10% in the afternoon trading session, with a current price of HKD 10.17 and a trading volume of HKD 17.37 million [1] - The company aims to utilize the net proceeds from its H-share listing to strengthen its capital base in key regions, with specific allocations for various markets [1] Group 2: Fund Allocation - 30% of the raised funds will be allocated to enhance operations in Hong Kong and expand into Malaysia [1] - 30% will be directed towards the UK and European markets [1] - 20% is planned for North American business development [1] - 10% will be used to expand operations in Singapore, with the remaining 10% allocated for general corporate purposes and working capital [1] Group 3: Business Performance - Nanhua Futures' overseas business is identified as a core competitive advantage, with projected overseas financial business revenue of CNY 654 million in 2024, representing a year-on-year growth of 15.3% [1] - The overseas revenue is expected to account for 48.3% of total revenue, significantly higher than industry peers [1] - The company and its subsidiaries hold derivatives trading and clearing licenses in major markets such as Hong Kong, the US, the UK, and Singapore, ensuring comprehensive coverage of key global futures trading hours [1]

Core Viewpoint - Nanhua Futures has successfully listed on the Hong Kong Stock Exchange, marking a significant milestone in the internationalization of China's futures industry and establishing a dual capital platform with A+H shares [1][2][3] Group 1: Company Overview and Market Position - Nanhua Futures is the second domestic futures company to achieve dual listing (A+H) after Hongye Futures, expanding the A+H futures company landscape to two [2] - The company has a market capitalization of approximately 120 billion RMB for A-shares and about 10 billion HKD for H-shares, totaling nearly 130 billion RMB, positioning it among the top in the domestic futures industry [2] - Nanhua Futures' H-share listing fills the gap for Chinese futures companies in the Hong Kong market in 2025, serving as a benchmark for cross-border IPOs in the non-bank financial sector [2][3] Group 2: Internationalization Strategy - Nanhua Futures has a 19-year history of internationalization, establishing its first overseas subsidiary in Hong Kong in 2006 and expanding to major financial centers including the US, Singapore, and the UK [4][5] - The company has developed a 24-hour trading service system across Asia, North America, and Europe, providing comprehensive derivatives trading, clearing, and risk management services [4] - Nanhua Futures has obtained membership qualifications from 18 major global exchanges and 15 clearing member qualifications, creating a competitive barrier that is difficult for domestic peers to replicate [5] Group 3: Financial Performance - In 2024, Nanhua Futures' overseas business revenue reached 654 million RMB, accounting for approximately 48.3% of total revenue, with a compound annual growth rate of 68.26% from 2022 to 2024 [6] - The gross profit margin of overseas business has consistently increased, reaching 71.26% in 2024, significantly higher than domestic business margins [6] - For the first three quarters of 2025, the company achieved revenue of 941 million RMB and a net profit of 351 million RMB, showing a slight decline of 1.92% year-on-year, outperforming the industry average [7] Group 4: Capital and Growth Potential - The net fundraising amount of 1.203 billion HKD from the H-share listing will enhance the capital strength of overseas subsidiaries, crucial for expanding international business and managing risks [8][9] - The dual capital platform provides flexible financing options, allowing the company to optimize financing methods based on market conditions, thereby reducing costs and enhancing risk resilience [9] - The internationalization of the futures industry is becoming essential for survival, driven by the increasing demand for cross-border risk management services as Chinese enterprises expand globally [10][11] Group 5: Future Outlook - Nanhua Futures is positioned to leverage its dual platform for significant growth in capital strength, brand influence, and business scale, potentially becoming a benchmark for the global futures industry [12][13] - The ongoing policy support for the opening of the futures market and the increasing demand for risk management services will provide long-term growth momentum for the company's overseas business [12][13]

Core Viewpoint - The Hong Kong IPO market experienced a rare event where four new stocks collectively fell below their issue prices on their first trading day, indicating a significant shift in market sentiment and performance [2][3]. Group 1: IPO Performance - Four new stocks listed on December 22, 2025, including Mingji Hospital, Impression Dahongpao, Huazai Biotechnology, and Nanhua Futures, saw declines of 49.46%, 35.28%, 29.32%, and 24.17% respectively, with Mingji Hospital's drop marking the largest first-day decline for a new stock since 2025 [2][4]. - In December 2025, out of 17 newly listed stocks, 9 experienced first-day declines, representing over 50% of the total, contrasting sharply with the strong performance of new stocks earlier in the year [3]. Group 2: Market Conditions - The overall liquidity environment in the Hong Kong market has tightened, with daily trading volumes on the Hong Kong Stock Exchange falling below 2 billion HKD, and net inflows from southbound funds significantly decreasing to 219.12 billion RMB in December [5][6]. - The Hang Seng Index, Hang Seng Tech Index, and Hang Seng China Enterprises Index all experienced declines of 1.10%, 2.82%, and 1.96% respectively during the week of December 15-19, 2025 [5]. Group 3: Factors Influencing Performance - The recent decline in new stock performance is attributed to multiple factors, including tightening liquidity, high valuations relative to fundamental performance, and regulatory changes affecting public fund holdings in Hong Kong stocks [7][8]. - Mingji Hospital's high price-to-earnings (P/E) ratio of approximately 29.8 times compared to the average P/E of 17 times for the private hospital sector in Hong Kong indicates a mismatch between valuation and fundamental performance [8][9]. Group 4: Regulatory Changes - The introduction of "Mechanism B" for IPOs allows issuers to set a lower limit on the proportion of shares available for public subscription, which can reduce the risk of mispricing but may also limit the ability of companies with high valuations to attract sufficient demand [9][10]. - Mingji Hospital utilized Mechanism B for its IPO, issuing 67 million shares with only 10% allocated for public sale, resulting in a limited float of approximately 394 million HKD [10].

Core Insights - The article highlights the top and bottom AH share premium rates, indicating significant discrepancies in market valuations between H-shares and A-shares for various companies [1][2][3]. Group 1: Top AH Share Premium Rates - Northeast Electric (00042) leads with a premium rate of 881.82%, followed by Zhejiang Shibao (01057) at 378.65% and Hongye Futures (03678) at 278.25% [1][2]. - Other notable companies in the top ten include Sinopec Oilfield Service (01033) with a premium of 271.01% and Chenming Paper (01812) at 253.42% [2]. Group 2: Bottom AH Share Premium Rates - CATL (03750) has the lowest premium rate at -12.06%, followed by China Merchants Bank (03968) at -2.43% and Heng Rui Medicine (01276) at 3.74% [1][3]. - Other companies with low premium rates include Weichai Power (02338) at 9.23% and Midea Group (00300) at 9.47% [3]. Group 3: Top AH Share Deviation Values - Nanhua Futures (02691) has the highest deviation value at 147.43%, followed by Zhejiang Shibao (01057) at 106.42% and Junda Co. (02865) at 51.86% [1][4]. - Other companies with significant deviation values include Guanghe Tong (00638) at 110.31% and China Shipbuilding Defense (00317) at 149.77% [4]. Group 4: Bottom AH Share Deviation Values - GAC Group (02238) shows the lowest deviation value at -27.72%, followed by CIMC (02039) at -11.53% and Zhaoyan New Drug (06127) at -10.54% [1][5]. - Other companies with negative deviation values include Jiangsu Ningshu Highway (00177) at -10.06% and Longfly Optical Fiber (06869) at -10.05% [5].